Nalotimagene carmaleucel
nalotimagene carmaleucel
human culture expanded activated allogeneic T cells for adjunctive immunotherapy. Cells are derived from the haematopoietic stem cell (HSC) donor and are genetically modified ex vivo with a non-replicative SFCMM-3 gamma- retroviral vector derived from Mo
human culture expanded activated allogeneic t cells for adjunctive immunotherapy. cells are derived from the haematopoietic stem cell (hsc) donor and are genetically modified ex vivo with a non-replicative sfcmm-3 gamma- retroviral vector derived from mo